Tag Archives: CMW Media

Canna-Hub Announces Launch of California’s Largest, Most Sophisticated Cannabis Real Estate Portfolio to Help Business Owners Capture Green Rush

SACRAMENTO, Calif., Sept. 12, 2017 /Weed Wire/ — Canna-Hub, a California-based real estate development and property management Company for the cannabis industry, today announced its innovative cannabis real estate development business model to help current and prospective cannabis licensees secure properly zoned property for their cannabis businesses in California.

Axim Biotech - MedChew Rx

AXIM Biotech Files Patent on Controlled Release Chewing Gum to Provide Opioid Addiction Treatment

NEW YORK, June 23, 2017 /Weed Wire/ — AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company filed with the United States Patent and Trademark Office (USPTO) for U.S. Application Serial Number 62/410,469, a patent of invention that involves a chewing gum composition with controlled release of cannabinoids and opioid agonists and/or antagonists for addiction and/or dependence treatment.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Investment Axim Biotech Announces Enrolled Patients Begin Phase II Trial for the Treatment of Irritable Bowel Syndrome (IBS) with CanChew Plus Cannabidiol (CBD) Chewing Gum

NEW YORK, March 7, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has enrolled 40 patients and commenced its Phase II clinical trial for the treatment of irritable bowel syndrome (IBS) with the company’s CanChew Plus® CBD gum.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Receives Brazilian Government Approval for Treatment of Autism Patient Using, Subsidiary, HempMeds® Brasil, Flagship Product RSHO™

SAN DIEGO, Calif., March 3, 2017/Weed Wire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States subsidiary, HempMeds® Brasil, today announced that the Brazilian government approved a prescription for the Company’s cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat a patient in the country with Autism Spectrum Disorder (ASD).

SeeThruEquity RSHO Raúl Elizalde

Multiple Sclerosis Approval: Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Receives Brazilian Government Permission for Import of Flagship Product RSHO™

SAN DIEGO, Calif., Feb. 21, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, subsidiary, HempMeds® Brasil today announced that the Brazilian government has authorized a doctor’s prescription for the Company’s hemp cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat patients in the country suffering from Multiple Sclerosis.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana Inc. Subsidiary, HempMeds, Announces New Affiliate Program Showcasing Customer Loyalty

SAN DIEGO, Calif., Feb. 13, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary HempMeds® is announcing a new affiliate program showcasing customer loyalty by allowing them to earn a commission by referring customers to the company.


Top